Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,949.0
-24.5 (-0.82%)

 

  • STI Straits Times Index
    2,949.0
    -24.5 (-0.82%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,577.8
    -3.8 (-0.24%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,980.2
    -1,094.0 (-3.64%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,509.1
    -76.0 (-2.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    -
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,241.8
    -47.8 (-0.76%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,281.1M
  • Value: 2,309.6M
  • Rise: 109
  • Fall: 262
  • Unch: 403

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
CWX Global0.007+0.002
Thomson Medical0.119-
Oceanus^0.071-0.004
Jiutian Chemical0.089-0.006
SPH1.400+0.120
Secura0.102-0.001
YZJ Shipbldg SGD1.070+0.010
Sembcorp Marine0.153-0.002
Anchor Resources0.015-
ThaiBev0.735-

World Indices

World Indices
Name Last Change
Nasdaq 13,119.4 -478.5
HSI 28,980.2 -1094.0
HSCEI 11,247.2 -470.2
Jakarta 6,241.8 -47.9
Nikkei 225 0.0
SSE Comp 3,509.1 -76.0
Shanghai A 3,678.3 -79.7
Shanghai B 243.4 -2.6
KOSPI 3,012.9 -86.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ASCENTAGE-B ASCENTAGE-B
Quotes 15 Minutes Delayed. Updated at 26 Feb 2021 16:09
Last (HKD): 34.150 Change: -1.250 High: 34.950 Remarks: -
Change (%): -3.53 Low: 33.150
Open 34.650 Yesterday's Close 35.400
Buy Price 34.000 Sell Price 34.150
Buy Volume ('000) 2 Sell Volume ('000) 42.9
Cumulative Volume ('000) 3,069.6 Cumulative Value 104,790,617
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -6.64350 Trailing EPS (HKD) e -5.12662 NAV (HKD) b 2.6540
PE a - Trailing PE f - Price / NAV b 12.8674
Dividend (HKD) d - Cash In Hand (HKD) g 1.8669 Issued & Paid-up Shares c 252,729,000
Dividend Yield (%) d - Price / Cash In Hand g 18.292 Treasury Shares h 12,229,000
Beta - 75 Daysi 1.629 R-Squared - 75 Days(%)i 11.07 Market Cap (M) 8,630.695
Beta - 500 Daysi 1.095 R-Squared - 500 Days (%)i 12.68 Enterprise Value (M) 8,248.719
Piotroski F Score 3 Exchange Code 6855 Par Value ( USD ) 0.00010
52 Weeks Volatility (%) 82.31 6-Month VWAP 41.237 Free Float (%) 41.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 26 Feb 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ASCENTAGE-B HKEx 8,630.695 - - 12.8674 -
Industry Biotechnology HKEx 47,066.463 - - 8.3315 0.121
Local Peer WUXI BIO HKEx 404,384.907 351.767 280.841 27.0708 -
Local Peer BEIGENE HKEx 225,347.715 - - 6.7819 -
Local Peer SINO BIOPHARM HKEx 162,363.379 52.899 63.447 4.5049 0.618
Local Peer ZAI LAB-SB HKEx 97,530.814 - - 27.0350 -
Local Peer JOINN HKEx 37,367.612 198.936 876.777 38.4991 0.146
Local Peer GENSCRIPT BIO HKEx 26,117.512 - - 3.5721 -
Local Peer 3SBIO HKEx 19,636.592 17.785 13.078 1.6787 -
Local Peer JW THERAP-B HKEx 15,412.399 - - -15.2075 -
Local Peer JACOBIO-B HKEx 15,429.240 - - -10.9745 -
Local Peer VIVA BIOTECH HKEx 12,858.507 42.652 - 6.1809 0.243
Local Peer ALPHAMAB-B HKEx 12,191.605 - - 4.3056 -
Local Peer FRONTAGE HKEx 10,259.628 71.044 97.092 4.8641 -
Other Local Peers HAOHAI BIOTEC (HKEx), JHBP-B (HKEx), KINTOR PHARMA-B (HKEx), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), REGENT PACIFIC (HKEx), CT ENTERPRISE (HKEx)
Global Peer AMGEN INC NASDAQ 131,407.816 18.090 18.090 13.9662 2.817
Global Peer CSL LTD ASX 119,481.601 38.096 31.394 11.3063 1.118
Global Peer GILEAD SCIENCES INC NASDAQ 78,738.660 640.126 640.152 4.3213 4.332
Global Peer ILLUMINA INC NASDAQ 65,050.974 99.163 99.163 13.8583 -
Global Peer MODERNA INC NASDAQ 58,715.450 - - 21.2753 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,366.281 20.418 20.418 6.3736 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 48,551.137 13.820 13.820 4.4036 -
Global Peer BIOGEN INC NASDAQ 42,236.679 10.558 10.558 3.9472 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 33,779.645 55.982 55.982 2.8992 -
Global Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 30,162.052 - - 7.0349 -
Other Global Peers SEAGEN INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), BEAM THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), FIBROGEN INC (NASDAQ), Lonza (SGX), VERACYTE INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ARVINAS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), ALKERMES PLC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), XENCOR INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NUVATION BIO INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), KYMERA THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), VOR BIOPHARMA INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), NGM BIOPHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BIOATLA INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SHATTUCK LABS INC (NASDAQ), PRECIGEN INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), UNIQURE N.V. (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), NKARTA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), OCUGEN INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), MANNKIND CORPORATION (NASDAQ), VAXCYTE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), OMEROS CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MESOBLAST LTD (ASX), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VANDA PHARMACE INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), INHIBRX INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CORTEXYME INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PASSAGE BIO INC (NASDAQ), HUMANIGEN INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PROTHENA CORP PLC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CHIMERIX INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), TELIX PHARMACEUTIC (ASX), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), VAXART INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), KADMON HLDGS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), AGENUS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), MERUS B V (NASDAQ), COMPUGEN (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), AKOUOS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ATRECA INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), MOLECULAR TEMPLATES INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ARDELYX INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), DPHARMA (Bursa), ALDEYRA THERAPEUTICS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AVROBIO INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), OPTHEA LIMITED (ASX), SQZ BIOTECHNOLOGIES CO (NYSE), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ONCORUS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SESEN BIO INC (NASDAQ), ATHERSYS INC (NASDAQ), IMMUNOME INC (NASDAQ), BIOVIE INC (NASDAQ), VERASTEM INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), IMUGENE LIMITED (ASX), XOMA CORP (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), FORTE BIOSCIENCES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), TREVENA INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), SURFACE ONCOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NEXTCURE INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), KAMADA LTD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALPINE IMMUNE